Certain peptides including BPC-157 have been identified by regulators as posing significant safety concerns in the compounding context
2021;54:797814.e796
All research must be conducted in accordance with applicable institutional, local, and federal regulations by qualified professionals
Dose: 0.25mg daily for weeks 1-2, increased to 0.5mg daily for weeks 3-6 Administration: Subcutaneous injection, rotating between deltoid area and upper chest near the shoulder Duration: 6 weeks total Supporting therapy: Light stretching daily, avoided overhead movements until week 4 Three months out from finishing the protocol, my shoulder still feels solid
Both peptides show favorable safety profiles in preclinical studies
In terms of selecting the formulation delivery device, in a human study with a whole-virus influenza liquid vaccine without adjuvant, the immune response was better when using the breath-powered Bi-Directional OptiNose device and nasal drops in the delivery, rather than traditional nasal spray and an oral spray [22]
